Share This Page
Drug Price Trends for NDC 50111-0648
✉ Email this page to a colleague
Average Pharmacy Cost for 50111-0648
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUOXETINE HCL 20 MG CAPSULE | 50111-0648-02 | 0.03134 | EACH | 2025-04-23 |
| FLUOXETINE HCL 20 MG CAPSULE | 50111-0648-44 | 0.03134 | EACH | 2025-04-23 |
| FLUOXETINE HCL 20 MG CAPSULE | 50111-0648-03 | 0.03134 | EACH | 2025-04-23 |
| FLUOXETINE HCL 20 MG CAPSULE | 50111-0648-01 | 0.03134 | EACH | 2025-04-23 |
| FLUOXETINE HCL 20 MG CAPSULE | 50111-0648-02 | 0.03216 | EACH | 2025-03-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 50111-0648
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| FLUOXETINE HCL 20MG CAP | AvKare, LLC | 50111-0648-03 | 1000 | 51.87 | 0.05187 | 2023-06-15 - 2028-06-14 | FSS |
| FLUOXETINE HCL 20MG CAP | AvKare, LLC | 50111-0648-01 | 100 | 4.40 | 0.04400 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Fluoxetine (NDC: 50111-0648)
Fluoxetine, a widely prescribed antidepressant, has been a significant player in the pharmaceutical market since its introduction. This article provides an in-depth analysis of the market trends and price projections for Fluoxetine, specifically focusing on the National Drug Code (NDC) 50111-0648.
Overview of Fluoxetine (NDC: 50111-0648)
Fluoxetine, marketed under the NDC 50111-0648, is a prescription drug manufactured by Teva Pharmaceuticals USA, Inc[1]. It belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and is primarily used to treat major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa[7].
Product Specifications
- Dosage Form: Capsule
- Route of Administration: Oral
- Strength: 20 mg/1
- Marketing Start Date: January 29, 2002
- Marketing Category: ANDA (Abbreviated New Drug Application)[1]
Current Market Status
As of 2024, Fluoxetine continues to be a significant player in the antidepressant market. Its generic availability has made it more accessible to a broader patient population, contributing to its sustained market presence.
Market Share and Competition
While specific market share data for NDC 50111-0648 is not provided in the search results, we can infer that as a generic version of Fluoxetine, it competes with other generic manufacturers as well as the brand-name version, Prozac.
The market is expected to reach USD 4.2 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 6.3% from 2024 to 2031[8].
This projection indicates a robust growth trajectory for the Fluoxetine market, including generic versions like NDC 50111-0648.
Pricing Analysis
Pricing in the pharmaceutical industry is complex and influenced by various factors. For Fluoxetine (NDC: 50111-0648), we need to consider both current pricing trends and future projections.
Current Pricing Trends
As a generic medication, Fluoxetine (NDC: 50111-0648) is generally priced lower than its brand-name counterpart. However, exact pricing can vary based on factors such as:
- Pharmacy location
- Insurance coverage
- Quantity purchased
- Discount programs availability
Factors Influencing Future Pricing
Several factors could impact the future pricing of Fluoxetine (NDC: 50111-0648):
- Market competition
- Raw material costs
- Regulatory changes
- Healthcare policy shifts
- Technological advancements in manufacturing
Supply Chain Considerations
The supply chain plays a crucial role in the availability and pricing of Fluoxetine (NDC: 50111-0648). Recent global events have highlighted the importance of a robust and resilient supply chain in the pharmaceutical industry.
Manufacturing and Distribution
Teva Pharmaceuticals USA, Inc., the manufacturer of this specific NDC, has a significant presence in the generic drug market. Their manufacturing capabilities and distribution network can influence the availability and pricing of Fluoxetine (NDC: 50111-0648).
Potential Supply Chain Disruptions
Factors that could potentially disrupt the supply chain include:
- Raw material shortages
- Manufacturing issues
- Transportation delays
- Regulatory hurdles
- Global health crises
Regulatory Environment
The regulatory landscape significantly impacts the market dynamics of pharmaceutical products, including Fluoxetine (NDC: 50111-0648).
FDA Regulations
As an FDA-approved generic drug, Fluoxetine (NDC: 50111-0648) must comply with stringent quality and safety standards. Any changes in these regulations could affect its market position and pricing.
National Drug Code (NDC) System
The NDC system, managed by the FDA, plays a crucial role in drug identification and reimbursement. Understanding this system is essential for analyzing the market position of Fluoxetine (NDC: 50111-0648).
Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which is a universal product identifier for human drugs in the United States[6].
Market Trends and Future Projections
Analyzing current trends and future projections is crucial for understanding the market dynamics of Fluoxetine (NDC: 50111-0648).
Growing Demand for Mental Health Treatments
The increasing awareness and destigmatization of mental health issues are driving the demand for antidepressants like Fluoxetine. This trend is expected to continue, potentially boosting the market for Fluoxetine (NDC: 50111-0648).
Technological Advancements
Advancements in pharmaceutical manufacturing and drug delivery systems could impact the production and administration of Fluoxetine, potentially affecting its market position and pricing.
Competitive Landscape
Understanding the competitive landscape is crucial for projecting the future market position of Fluoxetine (NDC: 50111-0648).
Generic Competition
As a generic drug, Fluoxetine (NDC: 50111-0648) faces competition from other generic manufacturers. This competition can exert downward pressure on pricing but may also drive innovation in manufacturing and distribution.
Emerging Treatments
The development of new antidepressants and alternative treatments for depression could impact the market share of established drugs like Fluoxetine. Staying abreast of these developments is crucial for accurate market projections.
Patient Demographics and Market Segmentation
Understanding the patient demographics and market segmentation is essential for projecting future demand and pricing trends for Fluoxetine (NDC: 50111-0648).
Age Groups
Fluoxetine is approved for use in both adults and children for certain conditions[7]. This broad age range contributes to its market potential.
Geographical Distribution
The demand for Fluoxetine may vary across different regions due to factors such as:
- Prevalence of depression and related disorders
- Healthcare infrastructure
- Cultural attitudes towards mental health
- Economic factors
Pricing Strategies and Reimbursement Policies
The pricing strategies adopted by Teva Pharmaceuticals and the reimbursement policies of insurance providers play a significant role in determining the market dynamics of Fluoxetine (NDC: 50111-0648).
Value-Based Pricing
There's a growing trend towards value-based pricing in healthcare. This could impact how Fluoxetine (NDC: 50111-0648) is priced, based on its demonstrated efficacy and cost-effectiveness.
Insurance Coverage and Reimbursement
The extent of insurance coverage and reimbursement policies for Fluoxetine can significantly influence its accessibility and, consequently, its market demand.
Research and Development
While Fluoxetine is a well-established drug, ongoing research and development efforts could impact its market position.
New Indications
Research into new therapeutic applications for Fluoxetine could potentially expand its market. For instance, studies are exploring its potential in treating conditions beyond its current approved indications.
Improved Formulations
Development of new formulations or delivery methods for Fluoxetine could enhance its efficacy or reduce side effects, potentially strengthening its market position.
Global Market Considerations
While our focus is on NDC 50111-0648, which is specific to the U.S. market, global trends in the antidepressant market can provide valuable insights into future projections.
Emerging Markets
The growing awareness and treatment of mental health disorders in emerging markets could drive global demand for antidepressants like Fluoxetine.
International Regulatory Harmonization
Efforts towards international regulatory harmonization could potentially impact the global market for Fluoxetine, including its pricing and distribution.
Key Takeaways
- Fluoxetine (NDC: 50111-0648) is a generic antidepressant manufactured by Teva Pharmaceuticals USA, Inc.
- The global antidepressant market is projected to grow at a CAGR of 6.3% from 2024 to 2031.
- Pricing of Fluoxetine is influenced by factors such as market competition, supply chain dynamics, and regulatory environment.
- The growing awareness of mental health issues is likely to drive demand for antidepressants like Fluoxetine.
- Future market position of Fluoxetine (NDC: 50111-0648) will depend on factors such as emerging treatments, pricing strategies, and potential new indications.
FAQs
-
Q: What is the significance of the NDC 50111-0648? A: The NDC 50111-0648 is a unique identifier for a specific Fluoxetine product manufactured by Teva Pharmaceuticals USA, Inc. It helps in tracking and managing the drug in the U.S. healthcare system.
-
Q: How might future regulatory changes affect the pricing of Fluoxetine (NDC: 50111-0648)? A: Regulatory changes could impact manufacturing standards, approval processes, or pricing policies, all of which could influence the cost of producing and distributing Fluoxetine, potentially affecting its market price.
-
Q: What role does generic competition play in the pricing of Fluoxetine (NDC: 50111-0648)? A: Generic competition typically leads to lower prices as multiple manufacturers compete in the market. This competition can help keep the price of Fluoxetine (NDC: 50111-0648) relatively stable or potentially drive it down over time.
-
Q: How might advancements in mental health treatments affect the market for Fluoxetine? A: New treatments or therapies for depression and related disorders could potentially impact the market share of established drugs like Fluoxetine. However, Fluoxetine's long-standing use and proven efficacy may help maintain its market position.
-
Q: What factors could lead to increased demand for Fluoxetine in the future? A: Factors that could increase demand include growing awareness and destigmatization of mental health issues, potential approval for new indications, and increased accessibility through improved healthcare coverage.
-
https://www.cms.gov/openpayments/downloads/drug-name-and-ndc-reference-data-instructions.pdf
-
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06d71a33-5578-4012-b11d-764f45bc1e6a
-
https://www.drugpatentwatch.com/p/drug-price/drugname/FLUOXETINE
-
https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
More… ↓
